Technology
Our Proprietary Platform: GENiBRx™
- Comprehensive Gene Selection
Our pan-cancer panel includes 624 carefully selected genes, covering a wide range of cancer-related pathways. - FDA Compatibility
GENiBRx™ is compatible with FDA-Approved Liquid Biopsy Tests, enhancing its diagnostic capabilities. - Extensive Reporting
Our platform provides comprehensive medical reporting, including SNVs, INDELs, and CNVs for thorough analysis. - Cloud-Based Access
Reports are accessible via cloud technology, allowing convenient viewing through email and digital applications.
Next-Generation Sequencing
- Sequencing Technology Overview
Next-generation sequencing (NGS) technology allows for rapid and comprehensive analysis of genetic material. - Benefits of NGS
Next-generation sequencing offers numerous benefits over traditional genetic testing methods, including speed, cost-efficiency, and data richness. - Accuracy and Reliability
NGS provides high accuracy and reliability metrics, making it a preferred choice for genetic analysis and testing.
AI-Powered Analysis
- Enhanced Variant Interpretation
Artificial intelligence improves the accuracy and speed of genetic variant interpretation, aiding in personalized medicine. - Machine Learning in Healthcare
Machine learning algorithms provide clinical decision support, enabling healthcare professionals to make informed decisions quickly. - Continuous Improvement
Continuous data collection allows AI systems to refine their algorithms, leading to improved accuracy and efficacy over time.
Address
100 Tower Drive, STE 238,
Burr Ridge, IL 60527
Hours
Monday - Friday
8am to 5pm